A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics and Safety of VIR-2218
Status:
Not yet recruiting
Trial end date:
2024-11-24
Target enrollment:
Participant gender:
Summary
The rationale of this study is to evaluate the impact of renal function on the PK, safety,
and tolerability of VIR-2218 in participants with normal renal function and participants with
varying degrees of renal dysfunction who are otherwise medically stable